[71] Data from the United Kingdom Clinical Practice Research Datalink showed that in patients with HbA1c 7%, a years delay in receiving treatment intensification was associated with significantly increased risk of MI, HF, composite CV events, and stroke by 67%, 64%, 62%, and 51%, respectively [72]
Also, downregulation of interferon stimulated genes such as MX1, IFITM1, and IFIT2 were observed in critical COVID-19 cases, as well as undetected messenger RNA levels of IFN- in blood (123)
and participation on advisory boards for Boehringer Ingelheim, GlaxoSmithKline, Madrigal, Novo Nordisk and Sagimet
Test from AED 99 at DCDC Dubai
These treatments are not as harsh as more advanced ones like laser and others
Fertil Steril (2013) 99(4):9981007